Nuveen Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $680K | Hold |
41,315
| – | – | ﹤0.01% | 2876 |
|
|
2024
Q3 | $1.02M | Sell |
41,315
-58,761
| -59% | -$1.45M | ﹤0.01% | 2750 |
|
|
2024
Q2 | $2.53M | Sell |
100,076
-96,100
| -49% | -$2.43M | ﹤0.01% | 2269 |
|
|
2024
Q1 | $4.98M | Sell |
196,176
-69,300
| -26% | -$1.76M | ﹤0.01% | 1998 |
|
|
2023
Q4 | $6.02M | Buy |
265,476
+128,369
| +94% | +$2.91M | ﹤0.01% | 1876 |
|
|
2023
Q3 | $2.55M | Buy |
137,107
+22,455
| +20% | +$418K | ﹤0.01% | 2202 |
|
|
2023
Q2 | $2.98M | Sell |
114,652
-6,560
| -5% | -$170K | ﹤0.01% | 2161 |
|
|
2023
Q1 | $3.48M | Buy |
121,212
+51,420
| +74% | +$1.48M | ﹤0.01% | 2087 |
|
|
2022
Q4 | $2.07M | Buy |
69,792
+15,079
| +28% | +$446K | ﹤0.01% | 2376 |
|
|
2022
Q3 | $1.3M | Sell |
54,713
-852
| -2% | -$20.3K | ﹤0.01% | 2618 |
|
|
2022
Q2 | $1.24M | Sell |
55,565
-3,449
| -6% | -$77K | ﹤0.01% | 2691 |
|
|
2022
Q1 | $1.59M | Buy |
59,014
+528
| +0.9% | +$14.2K | ﹤0.01% | 2618 |
|
|
2021
Q4 | $2.16M | Sell |
58,486
-3,785
| -6% | -$140K | ﹤0.01% | 2536 |
|
|
2021
Q3 | $2.47M | Sell |
62,271
-29,680
| -32% | -$1.18M | ﹤0.01% | 2578 |
|
|
2021
Q2 | $3.98M | Buy |
91,951
+27,254
| +42% | +$1.18M | ﹤0.01% | 2356 |
|
|
2021
Q1 | $2.64M | Sell |
64,697
-915
| -1% | -$37.3K | ﹤0.01% | 2484 |
|
|
2020
Q4 | $2.97M | Sell |
65,612
-1,864
| -3% | -$84.3K | ﹤0.01% | 2314 |
|
|
2020
Q3 | $2.39M | Buy |
67,476
+4,761
| +8% | +$168K | ﹤0.01% | 2291 |
|
|
2020
Q2 | $2.37M | Buy |
62,715
+9,267
| +17% | +$350K | ﹤0.01% | 2268 |
|
|
2020
Q1 | $1.55M | Sell |
53,448
-97,303
| -65% | -$2.81M | ﹤0.01% | 2312 |
|
|
2019
Q4 | $7.82M | Sell |
150,751
-60,919
| -29% | -$3.16M | ﹤0.01% | 1737 |
|
|
2019
Q3 | $11.6M | Buy |
211,670
+155,339
| +276% | +$8.53M | ﹤0.01% | 1472 |
|
|
2019
Q2 | $2.29M | Buy |
+56,331
| New | +$2.29M | ﹤0.01% | 2371 |
|